Enforcement Report - Week of November 15, 2023
Sun Pharma's Generic Buprenorphine & Naloxone Hydrochloride Receives Approval in the U.S.
Enforcement Report - Week of February 1, 2023
Suboxone settlement boosts Dr. Reddy’s Q1 net
Today, Wednesday, July 22, at the national conference of the Social Security Investment Company (Shasta), which will be held at the place of radio and television conferences with the aim of introducing the position of Shasta in the national economy, the pharmaceutical raw materials production company (Temad) is one of the group companies. Tamin Medicine (Tpico) will unveil three new and innovative products, two of which are produced for the first time in the country.
Aveva`s Generic Buprenorphine HCL Naloxone HCL Receives Approval in the U.S.
Alvogen`s Generic Buprenorphine HCl Receives Approval In US
Alkem`s Generic Buprenorphine HCl; Naloxone HCl Receives Approval In US
Indivior has reached an agreement to pay $600m to settle US claims that the company had run an illegal scheme to increase prescriptions of its opioid addiction treatment, Suboxone.